Giuliano Brunori
Overview
Explore the profile of Giuliano Brunori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carollo C, Mancia E, Sorce A, Altieri C, Altieri D, Brunori G, et al.
J Nephrol
. 2025 Feb;
PMID: 39960594
Background: The neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and derived-neutrophil-to-lymphocyte ratio (d-NLR), which can be obtained from complete blood count, have gained attention due to their widespread availability and low cost of...
2.
Baragetti I, Del Vecchio L, Ferrario F, Alberici F, Amendola A, Russo E, et al.
J Nephrol
. 2024 Oct;
38(1):225-234.
PMID: 39369368
Background: Systemic steroids are recommended for patients with IgA nephropathy (IgAN) and proteinuria. However, there are concerns about their safety due to an excess of serious adverse events (SAEs) in...
3.
Lomonte C, Ibeas J, Kitrou P, Giusto A, Baratto M, Bocchibianchi V, et al.
J Vasc Access
. 2024 Aug;
:11297298241265163.
PMID: 39097789
The Renal Expert in Vascular Access (REVAC) is one of the four modules of the Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) project, the first European-wide advanced training course...
4.
Leone P, Malerba E, Susca N, Favoino E, Perosa F, Brunori G, et al.
Front Immunol
. 2024 Mar;
15:1367875.
PMID: 38426109
The tumor microenvironment is a highly complex and dynamic mixture of cell types, including tumor, immune and endothelial cells (ECs), soluble factors (cytokines, chemokines, and growth factors), blood vessels and...
5.
De Rosa S, Ferrari F, Greco M, Pota V, Umbrello M, Cotoia A, et al.
J Anesth Analg Crit Care
. 2024 Feb;
4(1):16.
PMID: 38409062
Background: Septic shock, a critical condition characterized by organ failure, presents a substantial mortality risk in intensive care units (ICUs), with the 28-day mortality rate possibly reaching 40%. Conventional management...
6.
Verzola D, Saio M, Milanesi S, Picciotto D, Frascio M, Brunori G, et al.
Nephrol Dial Transplant
. 2024 Feb;
39(7):1201-1203.
PMID: 38400552
No abstract available.
7.
Napoli M, Guzzi F, Morale W, Lomonte C, Galli F, Lodi M, et al.
J Vasc Access
. 2024 Jan;
26(2):471-476.
PMID: 38235699
Background: Since in Italy there are no official data on vascular access (VA) for hemodialysis the Vascular Access Project Group (VAPG) of the Italian Society of Nephrology (SIN) designed a...
8.
Narasaki Y, Kalantar-Zadeh K, Rhee C, Brunori G, Zarantonello D
Nutrients
. 2024 Jan;
16(1).
PMID: 38201898
There is rising interest globally with respect to the health implications of vegetarian or plant-based diets. A growing body of evidence has demonstrated that higher consumption of plant-based foods and...
9.
Lenoci C, Gobber G, Brunori G
G Ital Nefrol
. 2023 Nov;
40(Suppl 81).
PMID: 38007826
Cancer and chronic kidney disease prevalence both increase with age. As a consequence, physicians are more frequently encountering older people with cancer who need dialysis, or patients on dialysis diagnosed...
10.
Prete M, Susca N, Leone P, De Giacomo A, Bray A, Brunori G, et al.
Lupus
. 2023 Oct;
32(13):1528-1535.
PMID: 37903488
Systemic lupus erythematosus (SLE) is a chronic and extremely disabling connective-tissue autoimmune disease with a tremendous impact on the quality of life (QoL). Belimumab, a B-lymphocyte-stimulator-specific inhibitor, is the first...